GSK-Barclays: Live Well

Partnership objectives

  1. Availability - develop a private sector supply chain to help reduce stock shortages and deliver essential medicines to rural areas.
  2. Access - establish small enterprise health outlets to deliver affordable healthcare in areas where people may otherwise have to travel significant distances to access basic healthcare.
  3. Affordability - test a micro health insurance product to help low-income people more easily afford medicines and healthcare services.
  4. Awareness - strengthen health education to help reduce sickness and mitigate its economic impact on poorer communities. 

Finding the right partners is key to making a real difference to the lives of many people in Zambia. Finding the right partners is key to making a real difference to the lives of many people in Zambia. Copyright GSK

What are the health needs and challenges?

Despite substantial economic growth in Africa over the last few decades, access to affordable healthcare remains one of the greatest challenges to sustained economic development. Sub-Saharan Africa accounts for 11% of the world’s population, yet bears 24% of the global disease burden and commands less than 1% of global health expenditure. It also faces a severe shortage of trained medical personnel, with just 3% of the world’s health workers deployed in Sub-Saharan Africa.

Description of partnership activities and how they address needs and challenges

The partnership shared vision is that in the future, economically sustainable and resilient health systems will be able to deliver affordable and accessible quality healthcare across Africa, while increasing access to financial products, supporting small business development and creating jobs.

To help achieve this, the partnership has implemented an initial pilot in Zambia to explore and address the economic and financial barriers that currently exist in health systems across Africa. By the end of 2016 Barclays and GSK will have together invested up to £7m in financial support and on the ground resource over a 3 year period, with the ambitious goal of reaching 1 million out of the total population of 14 million people living in Zambia. 

The partnership has been designed to align with the Zambian government’s National Health plans. Hon Joseph Kasonde, Minister of Health, Zambia has said: “We are very pleased to support the Barclays GSK Program which aligns well with priorities in the Zambian National Health Strategic Plan.” The partnership was also recognized by the Clinton Global Initiatives as a 2013 Commitment to Action. 

In Zambia, the partnership has set up the social enterprise, Live Well, in collaboration with CARE which tests a new route to market for GSK. Live Well recruits, trains and supports a network of Community Health Entrepreneurs (CHEs) in peri-urban and rural areas to promote healthcare and sell health impact products into underserved communities. Since the beginning of this project, over 300 CHEs have been recruited and 15,000 GSK products sold, which accounts for over 50% of total Live Well sales. It is anticipated that as the program grows across the country and to other countries GSK will reach a significant return on investment through expanded reach and increased volumes of sales.

At each step, GSK is working closely with other organisations such as government, NGOs and civil society as they develop thinking and plans. GSK hopes that ultimately, by working together, they can help unblock financial barriers and enhance government efforts to help increase access to affordable healthcare, ensuring the project is locally owned and self-sustaining.          


Together for Africa, building healthier futures

Partnership information

Company(ies) GlaxoSmithKline

Partner(s) Barclays, Zambia Ministry of Education

Type of Partner(s) Government, Other Business

Therapeutic Focus Neglected Tropical Diseases, Non-Communicable Diseases, Other, Vaccine-Preventable Diseases, Women and Children's Health, Infectious Diseases

Disease(s) Children's Health, General Health, Malaria, Respiratory Diseases, Rotavirus, Soil-Transmitted Helminthiasis

Program Type(s) Availability of Treatment - Differential Pricing, Availability of Treatment - Financial Support, Availability of Treatment - Product Donations, Health System Infrastructure - Development of Physical Infrastructure, Research & Development - Innovative Funding Mechanisms

Targeted Population(s) Children, Elderly, Marginalised / Indigenous People, Men, Mothers, Patients in needs of treatment, People with low income, Women, Youth

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Zambia

Start Date 2013

More information GSK Corporate Parnterships

Anticipated completion date Ongoing

« This innovative partnership has potential to develop sustainable private sector solutions that complement government efforts to improve essential medical supplies and healthcare for under-served communities in Zambia. »

Hon Joseph Kasonde, Minister of Health, Zambia